Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Plasminogen

The concentration of t-PA in human blood is 2—5 ng/mL, ie, 2—5 ppb. Plasminogen activation is accelerated in the presence of a clot, but the rate is slow. The dissolution of a clot requites a week or more during normal repair of vascular damage (17). Prevention of irreversible tissue damage during a heart attack requires that a clot, formed by mpture of an atherosclerotic plaque, be dissolved in a matter of hours. This rapid thrombolysis (dissolution of the clot) must be achieved without significant tibrinogenolysis elsewhere in the patient. [Pg.44]

Fig. 2. Outline of possible steps in the recovery and purification sequence for recombinant tissue plasminogen activator derived from recombinant CHO... Fig. 2. Outline of possible steps in the recovery and purification sequence for recombinant tissue plasminogen activator derived from recombinant CHO...
Fig. 3. Overview of puriftcation sequence for the nonrecombinant tissue plasminogen activator (t-PA) which also contains urokinase plasminogen activator (u-PA). Serum-free culture conditional media is from normal human ceU line. The temperature for aU. steps, except for size-exclusion chromatography... Fig. 3. Overview of puriftcation sequence for the nonrecombinant tissue plasminogen activator (t-PA) which also contains urokinase plasminogen activator (u-PA). Serum-free culture conditional media is from normal human ceU line. The temperature for aU. steps, except for size-exclusion chromatography...
S. E. Builder, R. van Reis, N. Paoni, and J. Ogez, "Process Development and Regulatory Approval of Tissue-Type Plasminogen Activator," in... [Pg.57]

Sequences have been determined for plasminogen and bovine Factor XII, and they are not homologous with the other serine proteases. The amino-terminal sequence of Factor XII is homologous, however, with the active site of several naturally occurring protease inhibitors (11). [Pg.173]

Protein G. This vitamin K-dependent glycoproteia serine protease zymogen is produced ia the Hver. It is an anticoagulant with species specificity (19—21). Proteia C is activated to Proteia by thrombomodulin, a proteia that resides on the surface of endothefial cells, plus thrombin ia the presence of calcium. In its active form, Proteia selectively iaactivates, by proteolytic degradation. Factors V, Va, VIII, and Villa. In this reaction the efficiency of Proteia is enhanced by complex formation with free Proteia S. la additioa, Proteia activates tissue plasminogen activator, which... [Pg.175]

Cryoprecipitate Fresh-frozen plasma Autoplex-T VIIFC VIIFvWFAg Fibrinogen Plasminogen Factor XIII all coagulation factors, r VIIFC 11 a, Vila, IXa, Xa DH American Red Cross American Red Cross Hyland, Immuno... [Pg.175]

Cryoprecipitate von VIIFvWFAg VIIFC, Fibrinogen Plasminogen Factor XIII Willebrand Factor products American Red Cross... [Pg.175]

The secondary stmcture of the plasminogen molecule, as determined by circular dichroism spectra, is 80% random coil, 20% beta-stmcture, and 0% alpha-helix. Electron microscopy has demonstrated the tertiary stmcture of plasminogen to be a 22- to 24-nm long spiral filament with a diameter of 2.2 to 2.4 nm. [Pg.179]

Although the precise mechanism of plasminogen activation is unknown, three principal theories have developed based on studies of the in vitro activation of native human plasminogen. Activation of native Glu-plasminogen in the absence of any plasmin inhibitor yields Lys —plasmin plus the so-called pre-activation peptides (PAP) formed by cleavage at LySg2 S E3 Activation takes place by a two-step mechanism in... [Pg.179]


See other pages where Plasminogen is mentioned: [Pg.57]    [Pg.445]    [Pg.582]    [Pg.769]    [Pg.769]    [Pg.769]    [Pg.995]    [Pg.995]    [Pg.995]    [Pg.995]    [Pg.1005]    [Pg.42]    [Pg.42]    [Pg.44]    [Pg.44]    [Pg.45]    [Pg.54]    [Pg.206]    [Pg.532]    [Pg.532]    [Pg.238]    [Pg.242]    [Pg.242]    [Pg.23]    [Pg.485]    [Pg.172]    [Pg.172]    [Pg.172]    [Pg.175]    [Pg.176]    [Pg.176]    [Pg.176]    [Pg.178]    [Pg.178]    [Pg.178]    [Pg.178]    [Pg.179]    [Pg.179]    [Pg.179]    [Pg.179]    [Pg.179]   
See also in sourсe #XX -- [ Pg.29 ]

See also in sourсe #XX -- [ Pg.604 ]

See also in sourсe #XX -- [ Pg.987 ]

See also in sourсe #XX -- [ Pg.143 ]

See also in sourсe #XX -- [ Pg.237 ]

See also in sourсe #XX -- [ Pg.346 , Pg.347 ]

See also in sourсe #XX -- [ Pg.40 , Pg.92 , Pg.257 ]

See also in sourсe #XX -- [ Pg.160 ]

See also in sourсe #XX -- [ Pg.144 , Pg.146 ]

See also in sourсe #XX -- [ Pg.381 ]

See also in sourсe #XX -- [ Pg.367 ]

See also in sourсe #XX -- [ Pg.320 ]

See also in sourсe #XX -- [ Pg.634 ]

See also in sourсe #XX -- [ Pg.725 ]

See also in sourсe #XX -- [ Pg.33 , Pg.42 ]

See also in sourсe #XX -- [ Pg.86 , Pg.98 ]

See also in sourсe #XX -- [ Pg.578 ]

See also in sourсe #XX -- [ Pg.313 ]

See also in sourсe #XX -- [ Pg.634 ]

See also in sourсe #XX -- [ Pg.37 , Pg.38 ]

See also in sourсe #XX -- [ Pg.3 , Pg.3 , Pg.166 , Pg.307 ]

See also in sourсe #XX -- [ Pg.85 ]

See also in sourсe #XX -- [ Pg.77 ]

See also in sourсe #XX -- [ Pg.433 , Pg.846 ]

See also in sourсe #XX -- [ Pg.262 , Pg.278 ]

See also in sourсe #XX -- [ Pg.375 , Pg.378 , Pg.1834 ]

See also in sourсe #XX -- [ Pg.189 ]

See also in sourсe #XX -- [ Pg.196 , Pg.354 ]

See also in sourсe #XX -- [ Pg.621 ]

See also in sourсe #XX -- [ Pg.838 , Pg.843 ]

See also in sourсe #XX -- [ Pg.634 ]

See also in sourсe #XX -- [ Pg.621 ]

See also in sourсe #XX -- [ Pg.960 ]

See also in sourсe #XX -- [ Pg.320 ]

See also in sourсe #XX -- [ Pg.634 ]

See also in sourсe #XX -- [ Pg.15 , Pg.128 , Pg.221 , Pg.222 , Pg.223 , Pg.270 ]

See also in sourсe #XX -- [ Pg.847 ]

See also in sourсe #XX -- [ Pg.672 ]

See also in sourсe #XX -- [ Pg.327 ]

See also in sourсe #XX -- [ Pg.268 , Pg.299 ]

See also in sourсe #XX -- [ Pg.357 ]

See also in sourсe #XX -- [ Pg.392 ]

See also in sourсe #XX -- [ Pg.392 ]

See also in sourсe #XX -- [ Pg.406 ]

See also in sourсe #XX -- [ Pg.123 ]

See also in sourсe #XX -- [ Pg.66 ]

See also in sourсe #XX -- [ Pg.72 ]

See also in sourсe #XX -- [ Pg.389 , Pg.394 , Pg.395 , Pg.568 ]




SEARCH



A-Plasminogen activator

APSAC (anistreplase anisoylated plasminogen streptokinase

Alteplase (Recombinant tissue-type plasminogen

Amiloride Analogs as Inhibitors of the Urokinase-type Plasminogen Activator

Anisoylated plasminogen streptokinase

Anisoylated plasminogen streptokinase activator

Anisoylated plasminogen streptokinase-activated complex

Anisoylated plasminogen-streptokinase activator complex

Anistreplase (anisoylated plasminogen-streptokinase activator

Antigen tissue plasminogen activator

Bat plasminogen activator

Cancer urokinase-plasminogen activator system

Catalytic domain of plasminogen activator

Cell Plasminogen

Clones/cloning tissue plasminogen activator

Earthworm plasminogen activator

Earthworm-tissue plasminogen activator

Endothelial cells, plasminogen activation

Engineered tissue plasminogen activator

Enzymatic plasminogen activators

Enzyme urokinase-plasminogen activator system

Enzymes tissue plasminogen activator

F-II cleavage of human plasminogen

FSH stimulation of tissue-type plasminogen activator

Fibrinolytic enzyme plasminogen activator

Global Utilization of Streptokinase and Tissue Plasminogen Activator

Glutamic plasminogen

Human plasminogen

Human tissue plasminogen activator

Human urokinase-like plasminogen

Lys-plasminogen

Malignancy urokinase-plasminogen activator system

Mexiletine Derivatives as Orally Bioavailable Inhibitors of Urokinase-Type Plasminogen Activator

Plant Kunitz serine protease inhibitor effects on ETI-a - plasminogen

Plasma Plasminogen

Plasma plasminogen urokinase

Plasminogen Activator Angioplasty

Plasminogen Activator Angioplasty Compatibility Trial

Plasminogen Platelet-activating factor

Plasminogen activating substances

Plasminogen activation

Plasminogen activation system

Plasminogen activation, and

Plasminogen activator , production

Plasminogen activator and

Plasminogen activator inhibitor

Plasminogen activator inhibitor PDGF)

Plasminogen activator inhibitor Platelet-derived growth factor

Plasminogen activator inhibitor type

Plasminogen activator inhibitor-1 (PAI

Plasminogen activator inhibitor-1 activity

Plasminogen activator staphylokinase

Plasminogen activator system

Plasminogen activator, recombinant

Plasminogen activator, recombinant tissue-type

Plasminogen activator-inhibitor , oxidative

Plasminogen activator-inhibitor , oxidative inactivation

Plasminogen activators

Plasminogen and plasmin

Plasminogen fibrin

Plasminogen fractionation

Plasminogen inhibitor , pharmacokinetics

Plasminogen inhibitors

Plasminogen inhibitors role in tissue protection

Plasminogen kringle types

Plasminogen plasma concentration

Plasminogen separation

Plasminogen streptokinase

Plasminogen streptokinase action

Plasminogen synthesis

Plasminogen thrombus

Plasminogen urokinase

Plasminogen, carbohydrate

Plasminogen, fragment

Plasminogen-activating inhibitors

Plasminogen-streptokinase, acylated

Plasminogen-streptokinase, acylated activator complex

Plasminogen/plasmin

Process synthesis tissue plasminogen activator

Promoters tissue plasminogen activator

Recombinant human tissue plasminogen activator

Recombinant tissue plasminogen

Recombinant tissue-plasminogen activator

Recombinant tissue-plasminogen activator rt-PA)

Recombinant tissue-type plasminogen

Recombinant tissue-type plasminogen as fibrinolytic enzymes

Salivary plasminogen activator

Serine proteases urokinase type plasminogen

Streptokinase-plasminogen complex

Stroke tissue plasminogen activator

The Urokinase-Plasminogen Activator System

Thrombolytic agent plasminogen activator

Tissue plasminogen

Tissue plasminogen activating

Tissue plasminogen activating factor

Tissue plasminogen activator

Tissue plasminogen activator (alteplase

Tissue plasminogen activator [tPA

Tissue plasminogen activator adverse effects

Tissue plasminogen activator cells

Tissue plasminogen activator connection

Tissue plasminogen activator infusion

Tissue plasminogen activator modified

Tissue plasminogen activator process

Tissue plasminogen activator purification

Tissue plasminogen activator recombinant (rtPA

Tissue plasminogen activator, therapeutic enzyme

Tissue plasminogen factor

Tissue-type plasminogen activator

Tissue-type plasminogen activator protein

Tissue-type plasminogen activator t-PA)

U-plasminogen activator

Urokinase plasminogen activator

Urokinase plasminogen activator receptor

Urokinase type plasminogen activator serine proteases

Urokinase-plasminogen activator inhibition

Urokinase-plasminogen activator system

Urokinase-type plasminogen activator

Urokinase-type plasminogen activator breast cancer

Urokinase-type plasminogen activator interactions

Urokinase-type plasminogen activator prostate cancer

Urokinase-type plasminogen activator protein

Urokinase-type plasminogen activator receptor

Urokinase-type plasminogen activator receptor uPAR)

Urokinase-type plasminogen activator uPAR

Vascular plasminogen activator

© 2024 chempedia.info